Original ArticleVision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study
Abbreviations and Acronyms
Cited by (0)
Supplemental material available at www.ophthalmologyretina.org.
Financial Disclosure(s): The author(s) have made the following disclosure(s): J.G.G.: Consultant – Novartis, Bayer, Allergan, Alcon, AbbVie.
J.S.: Consultant – Bayer, Novartis, Allergan.
C.H.: Consultant – Bayer, Sanofi.
T.S.: Employee and Equity owner – Bayer AG (Berlin, Germany).
T.N.: Employee – Bayer AG (Berlin, Germany).
O.S.: Employee – Bayer AG (Berlin, Germany) at the time this study was developed.
S.S.: Consultant – Novartis, Bayer AG (Berlin, Germany), Allergan, Roche, Optos, Heidelberg Engineering, Boehringer Ingleheim.
The AQUA study investigators: Alfredo Adan, Mikulas Alexik, Fareed Ali, Miguel Amaro, Vilma-Jurate Balciuniene, Francesco M. Bandello, Lluis Arias Barquet, Anna Beck, Katharina Bell, Francesco Boscia, Anniken Bures, Ângela Carneiro, David R. Chow, Andrius Cimbalas, Claudia Dahlke, Varma Deepali, John D. Dickinson, Michael Dollin, Chiara Eandi, Karl-Heinz Emmerich, Nicolas Feltgen, João Pereira Figueira, Oliver Findl, Monika Gajdošová, Richard P. Gale, Ivan John Galic, Justus Garweg, Vanessa Gasser-Steiner, Michel Giunta, John R. Gonder, Andrzej Grzybowski, Jan Hamouz, Lars-Olof Hattenbach, Frank G. Holz, Hasan Jesia, Jozef Kaluzny, Agnes Kerenyi, Peter J. Kertes, Frank Koch, Laurent Kodjikan, David E. Lederer, Ivana Liehneova, Katrin Lorenz, Andrew J. Lotery, Martin McKibbin, Geeta V. Menon, Zofia Michalewska, Edoardo Midena, Massimo Nicolo, Andras Papp, Gabriela Pavlovičová, Enrico Peiretti, Sara Vaz-Pereira, Paolo Perri, Ioannis Petropoulos, Frederic Queguiner, Krystyna Raczynska, Laura Sararols-Ramsay, Marek Rękas, Federico Ricci, Bozena Romanowska-Dixon, Helmut G. Sachs, Saddek Mohand-Said, Dirk Sandner, Ursula Schmidt-Erfurth, Walter Sekundo, Andras Seres, Sobha Sivaprasad, Eric Souied, João Castro de Sousa, Andrzej Stankiewicz, Jana Štefaničková, Katarína Struhárová, Jan Studnicka, Enrique Cervera Taulet, Simon Taylor, Slawomir Teper, Attila Vajas, Carlos Cava Valenciano, Balázs Varsányi, Francesco Viola, Gianni Virgili, Lars Wagenfeld, Gavin Walters, Peter Wiedemann, Tomasz Zarnowski.
Supported by Bayer AG, Berlin, Germany. The sponsor or funding organization participated in the design of the study; conducting the study; data analysis; interpretation of the data; and preparation, review, and approval of the manuscript.
Medical writing assistance was provided by Deepti Sharda and Melanie Meister-Broekema of PAREXEL, and was funded by Bayer.
HUMAN SUBJECTS: Human subjects were included in this study. The study was conducted in 78 sites across 14 countries in Europe and Canada. Institutional review board or ethics committee approval was obtained at each site before, and informed consent to participate in the study was obtained from all patients. All information presented in this study complies with the Health Insurance Portability and Accountability Act for United States sites. The study was performed in accordance with the tenets of the Declaration of Helsinki.
No animal subjects were included in this study.
Author Contributions:
Conception and design: Garweg, Stefanickova, Hoyng, Schmelter, Niesen, Sowade, Sivaprasad
Analysis and interpretation: Garweg, Stefanickova, Hoyng, Schmelter, Niesen, Sowade, Sivaprasad
Data collection: Garweg, Stefanickova, Hoyng, Sivaprasad
Obtained funding: N/A
Overall responsibility: Garweg, Stefanickova, Hoyng, Schmelter, Niesen, Sowade, Sivaprasad
- †
Deceased.